Brazil regulator rejects import of Russian vaccine.

Brazil's National Health Regulation Agency (Anvisa) has declared itself against the import of the Russian Covid-19 vaccine Sputnik V.
covid-19-vaccine-Latam

Brazil’s National Health Regulation Agency (Anvisa) has declared itself against the import of the Russian Covid-19 vaccine Sputnik V.

The agency lacks “consistent and reliable data,” it said in a statement late on Monday evening. The decision was unanimous after about five hours of deliberations.

However, Anvisa director Alex Machado Campos stressed that the decision was only a “snapshot.”

Shortcomings were identified in both the development and the production of the vector vaccine, according to the statement, based on the data that could be analyzed so far. This includes all three phases of the clinical trials of the preparation, it said.

covid-19-vaccine-Latam

“In addition, there is insufficient or no data on quality control, safety and efficacy,” the agency wrote.

So far, 14 states in Latin America’s largest country have asked for permission to import Sputnik V in view of the dramatic coronavirus situation.

Brazil, with its approximately 210 million inhabitants, is one of the hotspots of the coronavirus pandemic. According to the Ministry of Health, more than 14 million people have been infected with the coronavirus and about 390,000 patients have died in connection with Covid-19.

Share:

Share on linkedin
Share on twitter
Share on facebook

More Posts

cancer-clinical-trial

Cancer Research: Types of clinical trials.

Patients with cancer who participate in cancer clinical trials receive the most effective therapy currently available or they may receive treatments that are being evaluated for future use.

Send Us A Message